Vascular & Endovascular

The FDA has announced a Class I recall for 1.1 million packages of CoaguChek XS PT test strips used with point-of-care or in-home devices to adjust warfarin dosing.

Ischemic stroke patients—regardless of their individual characteristics or the severity of their stroke—are 20 percent more likely to be readmitted to the hospital within 30 days of discharge if they acquire any kind of infection during their initial stay, researchers reported Nov. 1 in Stroke.

Eight European scientific societies joined forces to produce what they say is the first interdisciplinary position paper to help clinicians manage patients with patent foramen ovales (PFOs).

A 12-week round of robotic arm rehabilitation might improve speech and language outcomes in chronic stroke patients with aphasia, according to preliminary results of a small-scale study published in Frontiers in Neurology.

The FDA has approved canagliflozin (Invokana) to reduce the risk of major adverse cardiovascular events (MACE) including stroke, heart attack and cardiac death in patients with type 2 diabetes and established cardiovascular disease. It is the first oral diabetes medication to gain this indication, according to drug manufacturer Janssen Pharmaceutical Companies.

The expanded window for thrombectomy in acute stroke care ranked No. 3 on Cleveland Clinic’s top 10 medical innovations for 2019—one of several developments on the list with implications for cardiovascular treatment.

A therapeutic vaccine developed in Japan could work as well as oral antithrombotic drugs to prevent secondary ischemic stroke, according to preliminary research published Oct. 29 in Hypertension.

Researchers from Northwestern University developed an easy-to-calculate, four-factor score which identified 92.2 percent of true strokes among 330 inpatients who triggered stroke alerts.

A simple score containing four MRI markers of cerebral small vessel disease (CSVD) is associated with stroke, dementia and mortality among older adults, according to an analysis of the population-based Rotterdam Study published Oct. 24 in Stroke.

A team of Chicago researchers has identified four genetic variants specific to people of African ancestry which may help explain their increased incidence of warfarin-associated bleeding events.

Aspirin alone may be sufficient to balance the risks of venous thromboembolism (VTE) and bleeding following total knee replacement surgery, according to a study published online in JAMA Surgery.

Recreational marijuana use is linked to an increase in stroke prevalence in the U.S. population, according to a study presented at the 11th World Stroke Congress in Montreal. Results of the study were released just two days after Canada legalized recreational cannabis nationwide.